@article{904329ec06f34408982da3f98e41da25,
title = "Activation-induced T-cell exhaustion: too much of a good thing?",
author = "Ansell, {Stephen M.}",
note = "Funding Information: Stephen Ansell received research funding (to his institution for clinical trials) from Bristol Myers Squibb, Merck, Seattle Genetics, Regeneron, Trillium, AI Therapeutics, Pfizer and Affimed. Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = jan,
day = "28",
doi = "10.1080/10428194.2019.1703973",
language = "English (US)",
volume = "61",
pages = "255--256",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "2",
}